Expression and signalling through the pre-TCR and the TCRab resemble two critical checkpoints during T cell development. We investigated to which extent a pre-TCR can functionally replace mature TCRa chains during T cell development. For this purpose, transgenic mice were generated expressing the pre-TCRa (pTa) under the transcriptional control of TCRb regulatory elements. We report here on the interesting finding that constitutive pTa expression allows complete T cell maturation. The pre-TCR complex permits a subset of b-selected thymocytes to mature in the absence of TCRa into peripheral T cells (bT cells) comprising up to 10% of all lymphocytes. Lymphopenia-driven proliferation of these bT cells is similar to that of conventional abT cells. Furthermore, bT cells proliferated and acquired effector function upon stimulation with allogeneic MHC.
Introduction
The formation of a clonally distributed antigen receptor (AgR) repertoire on B and T lymphocytes hallmarks the adaptive immune system. The antigen-binding sites of both B and T cell AgRs are shaped by heterodimerization of the amino-terminal variable (V) domains of Ig heavy and light chains, TCRa and b or TCRc and d chains, respectively (1) . The ontogeny of B and T cells is characterized by a sequential acquisition of their clonotypic AgR chains (2) (3) (4) (5) . To compensate for the transient lack of the secondary chain, both B and T cells make use of the so-called surrogate receptor chains to form the pre-BCR and pre-TCR complexes, in which the surrogate light chain (a disulphide-linked heterodimer between a VpreB and k5) or the pre-TCRa (pTa) chain replaces the lacking IgL and TCRa chain, respectively (3, (6) (7) (8) . Expression of the precursor forms of AgRs is associated with increased survival, rapid clonal expansion, further differentiation and rearrangement of the secondary AgR genes. The subsequent expression of clonotypic AgR complexes and their selection into the mature lymphocyte pool is accompanied by transcriptional shutdown of the surrogate AgR chains.
Regarding abT cells, the stages of intra-thymic development can be traced by their differential expression of CD4, CD8, CD25 and CD44 (9 (DN III) and CD25 ÿ 44 ÿ (DN IV). While rearrangements of D (diversity) and J (joining) segments at the TCRb locus are found in DN I cells already, the vast majority of V (variability) to DJ rearrangements occur in resting DN III cells. If productive, the TCRb chain is disulphide linked to pTa and assembles with pre-formed CD3 components into a pre-TCR-CD3 complex, which appears at very low levels at the cell surface. The pre-TCR signals ligand independently causing the progression of late resting TCRb-negative proT cells of 'expected size' (DN III E) into 'large', cycling pre-T cells (DN III L), a process known as b-selection (10) . The term b-selection has been introduced to characterize a critical checkpoint by which only those T cells are selected for further maturation that have undergone successful rearrangement of their TCRb allele (10, 11) . DN III L cells initiate VJ rearrangements at the TCRa locus and continue development by down-regulation of CD25 to yield DN IV cells. After a transitional CD4 ÿ 8 + immature single-positive (ISP) stage they develop into small resting, CD4 + 8 + doublepositive (DP) thymocytes. The expansion of DN III L cells accounts for the generation of most abT cell precursors, increasing the efficacy of TCRab repertoire formation and counteracting the substantial cell loss associated with positive and negative selection of DP ab thymocytes (4, 12) . Further differentiation and selection into mature T cell subsets require a functional VJ rearrangement at the TCRa locus and expression of a TCRa chain capable of assembling into TCRab-CD3 complexes. The interaction of the clonotypic TCRab with peptide MHC (pMHC) ligands in the thymus determines the outcome for positive and negative selection.
Remarkably, the contribution of the TCRa and b chain in recognizing specific pMHC complexes varies considerably in that it can be largely determined by TCRa, TCRb or both (for review see 13, 14) . According to the affinity model, negative selection or neglection involves clonal elimination of those thymocytes that interact either too strong or too weak with pMHC, respectively (for review see 15). Positive selection is associated with the up-regulation of TCRab/CD3 surface expression levels, transcriptional down-regulation of pTa and reduced expression of the T cell 'immaturity marker' (HSA). The final commitment into MHC class II-restricted CD4 + 8 ÿ helper or MHC class I-restricted CD4 ÿ 8 + cytotoxic T cell lineage is marked by the shutdown of CD8 or CD4 co-receptor expression and migration into peripheral lymphatic tissues (for review see 16) .
Peripheral abT cells derive from intermediate-affinity self-MHC-restricted, positively selected thymocytes, which represent a very small fraction of T cell precursors. Despite the fact that the pre-TCR complex uses the same signalling cascades as the TCRab, signals arising from the pre-TCR appear to be ligand independent, i.e. pre-T cell development can proceed normally in the absence of the intra-and extracellular TCRb and pTa domains (17-21) and does not require MHC expression (22) .
We here addressed the developmental potential of precursor T cells, constitutively expressing the pTa chain under the transcriptional control elements of the TCRb promotor. Constitutive expression of the pre-TCR permits a subset of b-selected thymocytes to mature, giving rise to peripheral pTa/TCRb/TCRa ÿ / ÿ cells. The developmental and functional potential of this novel population of peripheral T cells from pTa transgenic (tg)/TCRa ÿ/ÿ mice has been addressed and the potential consequences in regard to the complexity of AgR formation are discussed.
Methods

Mice
Mice deficient in TCRa or Rag2 were purchased from Jackson Laboratories. Nude mice were obtained from Bomholtgaard as BLACK-nu and conventional C57Bl/6 mice from Charles River (Wilmingtion, MA, USA). Mice deficient in pTa were kindly provided by J. Fehling and H. von Boehmer (23) . Mice were maintained under specific pathogen-free conditions and used for experiments at 6-8 weeks of age. All animal experiments were performed according to institutional and national guidelines.
Generation of pTa tg mice
A transgene was derived by placing a genomic fragment encompassing exon 2-4 of mouse pTa coding region under the control of TCRb transcription elements. The construct is based on a 20-kb genomic KpnI fragment that originates from the 36-kb insert of cosHYb9-1.14-5 (24) and contains the rearranged HY-TCRb gene including the transcription elements of the TCRb locus (25) . The DV-TCRb mutant was derived by deleting most of the VDJ region, which encodes a small NH 2 -terminal tag of 12 aa (comprising 6 N-terminal amino acids of Vb8.2 and 6 C-terminal amino acids of Jb2.3) and the complete constant region of TCR Cb2 (26) . The DVTCRb transgene was further modified by deleting a genomic 6.1-kb BamHI fragment containing the TCRb constant region (Cb2) and inserting a genomic ClaI-flanked EcoRV/HindIII fragment of 3.5 kb containing exon 2-4 of mouse pTa (27) into a unique ClaI site located just upstream of the deleted BamHI fragment. To enable release of the pTa transgene by KpnI digestion, the intronic KpnI site within pTa was destroyed. Three independent founder lines were established by microinjecting the 17-kb KpnI fragment into fertilized BDF1 (H2-D b ) mouse oocytes. The DVtag allows differential detection of the pTa transgene and products. The genotype of pTa tg mice was determined by PCR, making use of the DVtag-specific primer (CACATGGAGGCTGCAACCAGACTG) and a reverse pTa primer (CGGAAAGGGGGTGCCAGCGATGC). Mice were back-crossed on the C57Bl/6 background for at least six generations.
Forward primer used for reverse transcription (RT)-PCR on pTa hybridizes at start of exon 2 (ATCACACTGCTGGTA-GATGGA) and the reverse primer 20-bp downstream of stop codon (TCAGAGGGGTGGGTAAGATC).
Flow cytometry staining
Single cells from thymus, spleen or blood were obtained and RBCs were lysed. Cells were incubated for 15 min on ice with specific antibodies conjugated to FITC, PE, APC or biotin as indicated; biotinylated mAbs were revealed with streptavidinPerCP. All Antibodies were purchased from BD PharMingen. Surface expression for pTa was performed according to manufacturer's protocol. Intracellular stainings for TCRb, IFNc and Granzyme B (GrB) were performed with the CytofixCytoperm Kit from Becton Dickinson (Alphen aan den Rijn, The Netherlands). Analysis was performed on a FACS Calibur using Cell Quest Software. Viable cells were gated on the basis of propidium iodide exclusions.
Foetal liver cell reconstitution and thymus transplantation
Foetal liver (14.5 dpc) cell suspensions from individual, genotyped pTa tg/TCRa ÿ/ÿ embryos of pTa tg/TCRa ÿ/ÿ and TCRa ÿ/ÿ time mated mice were injected intravenously into sub-lethally irradiated (4 Gy) 4-week-old nude mice. Eleven weeks after the reconstitution with foetal liver cells, some of the nude mice were analysed for the presence of bT cells. A subset of the reconstituted nude mice received a thymus transplant from 15.5 dpc Rag2-deficient embryos under the kidney capsule. Six weeks after transplantation, the reconstituted and transplanted nude mice were analysed for the presence of bT cells.
Adoptive transfer
bT or abT cells were sorted and labelled with CFSE (Invitrogen, Breda, The Netherlands). Half a million cells were injected intravenously into Rag ÿ/ÿ . Seven and 16 days later, lymph nodes (LNs) and spleen were isolated and cells were stained with anti-CD3-PE and anti-CD90-APC for flow cytometric analysis.
Stimulation of primary abT, cdT and bT cells
Cells were sorted on the basis of CD3e, CD90 and TCRcd staining and stimulated for 3 days with either ConA (5 lg ml ÿ1 ) or plate-bound anti-CD3e mAb (50 lg ml ÿ1 , clone 145.2C11). Proliferation was measured by [ 3 H]thymidine incorporation.
Allogenic response
C57Bl/6, pTa tg/TCRa ÿ/ÿ and TCRa ÿ/ÿ mice were challenged intra-peritoneally with three to five million irradiated Balb/c splenocytes (50 Gy) on week 0, 2 and 6. Two weeks after the last boost, splenocytes were labelled with CFSE, and restimulated in vitro with irradiated (80 Gy) EL-4 (H-2 b ) or P815 (H-2 d ) cells at a ratio of 1 responder:10 stimulators in the presence of IL-2 (10 U ml ÿ1 ). Using the CFSE profile of bT cells from day 1, 3, 4 and 6, proliferation parameters such as responder frequency (the number of initial cells that are responding), burst size (the magnitude of the response) and proliferative capacity (average number of divisions of activated cells) were calculated as described (28) . GrB production was determined after 10 days of in vitro culture and adding fresh IL-2 on day 3.
Results
Generation of tg mice expressing pTa throughout T cell development
To express the pTachain constitutively in all Tcells, a transgene was derived that places pTa under the transcriptional control elements (25) of the TCRb locus. Three founders were identified by Southern blot and PCR analysis ( Fig. 1A and B) .
To ensure that the tagged pTa transgene is functional, the transgene was introduced into a pTa-deficient background and T cell development in pTa tg and non-tg pTa-deficient (pTa ÿ/ÿ ) and proficient mice was analysed. As expected, the pTa transgene compensates for the developmental block that pTa ÿ/ÿ thymocytes encounter at the DN III stage of development (23, 29) . The presence of tg pTa restores progression of DN III into DN IV, ISP and DP thymocytes, normalizes the ratio of CD4/CD8 subsets in pTa tg/pTa ÿ/ÿ thymi and increases the cellularity from about 10% in pTa ÿ/ÿ to 50% in pTa tg/pTa ÿ/ÿ , relative to wild-type levels (Fig. 1C) . The failure of tg pTa to reconstitute the thymus cellularity completely likely relates to a general observation of reduced thymic cellularity in TCR and pTa tg mice (4). In pTa ÿ/ÿ mice, the development of cdT cells is favoured. As expected, the pTa transgene restores the development of abT cells and simultaneously reduces the frequency and number of cdT cells to wild-type levels. In conclusion, the constitutively expressed pTa transgene is capable of reconstituting b-selection in pTa ÿ/ÿ mice.
Identification of a novel peripheral T cell subset in pTa tg mice
In order to reveal any obvious differences in the composition of peripheral T cell subsets in pTa tg mice compared with non-tg mice, the T cell subsets of the three independent pTa tg founder lines were analysed by flow cytometry using the T cell markers CD3e-, CD4-, CD8a-and CD90.2 (Thy1.2)-specific mAbs. Interestingly, in pTa tg mice, a unique T cell subset expressing high levels of CD90 and low level of CD3 could be identified, that is virtually absent in non-tg littermates. This subset is clearly distinguishable from conventional abT or cdT cells expressing high levels of CD3 ( Fig. 2A) . Within the CD90 high CD3 low population, the majority of T cells lack CD4 and CD8 co-receptors, 20-40% express the CD8 and 1-3% express CD4. In all three founder lines, the CD90 high CD3 low population constitutes 2-5% of peripheral lymphocytes and 5-15% of T cells ( Fig. 2A) . Like the vast majority of mature abT cells, these T cells resemble small lymphocytes that do not express CD25, CD44 or CD69 (data not shown). In conclusion, constitutive expression of pTa allows the development of a unique CD90 high CD3 low T cell population. In pTa tg mice, CD90 high CD3 low T cells constitute 2-5% of peripheral lymphocytes and coexist with conventional abT cells. Whether their number and development are influenced in trans by abT cells or in cis by TCRa expression was addressed by crossing the pTa tg onto a TCRa-deficient background. In pTa tg/TCRa ÿ/ÿ mice, conventional abT cells do not develop. In the absence of TCRa, the frequency of CD90 high CD3 low cells increases from 2-5% to 8-10% of peripheral lymphocytes (Fig. 2B) . The relative increase is accompanied by a 2-to 3-fold increase in their absolute number (from 2 6 0.6 3 10 6 to 8.7 6 1.0 3 10 6 ), which likely relates to a compensatory lymphopenic proliferation due to the absence of abT cells (see below). Besides CD90 high CD3 low T cells, a CD90 high CD3 high cdT cell population is found. The CD8 co-receptor is generally expressed as a CD8aa homodimer on cdT cells and as a CD8ab heterodimer on cytotoxic abT cells (30) . The CD8 + subset of CD90 high CD3 low T cells expresses only the heterodimeric form of CD8 (Fig. 2B) . In summary, a constitutively expressed pTa chain gives rise to a novel subset of mature CD90 high CD3 low T cells, but fails to compensate numerically the lack of abT cells in a TCRa-deficient background. Based on flow cytometry, these CD90 high CD3 low T cells express low levels of TCRb and CD3 in a stoichiometric ratio at the cell surface (data not shown). As these CD90 high CD3 low T cells develop independent of the TCRa chain but express constitutively a b/pTa TCR, they are hereafter referred to as bT cells.
Surface staining showed that these CD90 high CD3 low bT cells express low levels of TCRb (Fig. 2C) . Additionally, surface staining for pTa showed that bT cells express indeed pTa, in contrast to CD90 high CD3 high cdT cells and abT cells from wildtype mice (Fig. 2C) . Furthermore, bT cells express full-length pTa as determined by RT-PCR (Fig. 2D) supporting that bT cells require pTa expression. This also excludes the possibility that bT cells express a truncated splice variant of pTa lacking the extracellular domain, as has been shown in TCRb-only cells of TCRa-deficient mice (31) . Interestingly, pTa transcripts do not occur in CD90
high CD3 low cells of TCRa-deficient mice explaining the absence of bT cells in those mice. The detection of tg pTa expression in cdT cells is consistent with the TCRb promotor activity in those cells.
bT cells are related to abT cells
To examine whether bT cells are indeed thymus derived, dpc 14.5 foetal liver cells from pTa tg/TCRa ÿ/ÿ mice were adoptively transferred into sub-lethally irradiated nude mice, which are thymus deficient. Eleven weeks after reconstitution, the mice were analysed for the presence of bT cells (Fig. 3A) . The absence of bT cells in the reconstituted nude mice implies their thymic origin. Indeed, when the pTa tg/TCRa ÿ/ÿ foetal liver reconstitution was followed by transplantation of dpc 15.5 foetal Rag2 ÿ/ÿ thymic lobes 6 weeks after transplantation, the peripheral T cell compartments of these mice contained, besides the expected conventional T cells from host-derived bone marrow stem cells, foetal liver stem cell-derived bT cells (Fig. 3A) . Thus, the thymus transplant supports the development of bT cells clearly demonstrating the thymic origin of bT cells.
Given the finding that bT cells express low levels of TCR-CD3 complexes, we made use of CD3 and the immaturity marker CD24 to distinguish mature bT cells (CD3 low CD24 low ) from mature ab/cd thymocytes (CD3 high CD24 low ) and immature thymocytes (CD3 low CD24 high ) (Fig. 3B) . In pTa tg mice, a small CD24 low CD3 low thymic compartment develops that is virtually absent in wild-type and TCRa ÿ/ÿ mice. This compartment is even more prominent in pTa tg/TCRa ÿ/ÿ mice. The TCR co-receptor expression pattern of these CD24 low CD3 low thymocytes is similar to the one found on peripheral bT cells. The low frequency (0.1-0.2%) of mature bT cells in pTa tg as well as pTa tg/TCRa ÿ/ÿ thymi suggests that the maturation of bT cells underlies rigid selection.
In summary, bT cells develop independently of conventional abT cells and do not require TCRa chain expression. In addition, consistent with the expected requirement of a functionally rearranged TCRb locus, bT cells do not develop in pTa tg/Rag2-deficient mice (data not shown).
Proliferation and survival of bT cells in vivo and in vitro
To further elucidate whether bT cells resemble mature lymphocytes, the proliferative and survival capacity of bT cells was compared with that of abT cells in vivo. A total of 0.5 million sorted bT and abT cells from spleens of pTa tg/TCRa ÿ/ÿ mice and wild-type mice, respectively, were labelled with CFSE and adoptively transferred into Rag-deficient mice. Seven and 16 days after transfer, peripheral lymphoid compartments of three recipient mice were pooled for the analysis for presence and proliferation of bT cells and abT cells in vivo (Fig. 4A) . The number and proliferative capacity of bT and abT cells were very similar. The low event number is explained by the low number of transferred cells. Apparently, in this lymphopenic setting, the homeostasis of bT cells is similar to that of abT cells. The fact that only mature T cells undergo lymphopenic proliferation in peripheral organs indicates that bT cells resemble mature T cells.
Besides homeostatic proliferation, the responsiveness of bT cells to polyclonal T cell stimuli was examined in vitro. Both ab and cd T cells are known to proliferate in response to the T cellspecific lectin ConA or to cross-linking of their TCR complexes with coated CD3-specific mAbs. Peripheral bT cells do not proliferate in response to ConA, but mount a normal proliferative response upon cross-linking with CD3-specific mAb (Fig. 4B) . The failure of bT cells to respond to ConA suggests differential glycosylation and/or binding/cross-linking capability of ConA to the highly expressed TCRab on T cells compared with the low levels of pre-TCR on bT cells. The fact that peripheral bT cells proliferate rather than die in response to CD3 cross-linking is an additional indication that peripheral bT cells resemble mature T cells.
bT cells respond to allogenic MHC
Apparently, a subset of thymocytes expressing the pTa chain constitutively develops in a thymus-dependent manner into mature bT cells. These bT cells derive from a large pool of DP thymocytes and share many features with conventional abT cells. We further analysed the functional capacity of bT cells. We determined whether H-2 b -derived bT cells are capable of mounting a response to allogenic MHC. pTa tg/TCRa ÿ/ÿ and wild-type mice (H-2 b ) were immunized three times with allogenic splenocytes (Balb/c, H-2 d ) and splenocytes were re-stimulated in vitro with the tumour cell line P815 (H-2 d ) or EL4 (H-2 b ) (Fig. 5A) . The percentage of cells that had been triggered to divide (responder frequency) and the mean of divisions among those cells that had divided at least once (burst size) were calculated according to Walmsley (28) . Consistent with published estimates, the responder frequency of normal mice towards allogenic stimulators is in the range of 1-10% (32). Intriguingly, a subset of bT cells (4%) is capable of responding to allogenic stimulators (Fig. 5B) . The CD4 ÿ CD8 ÿ , CD4 + or CD8 + bT cells participate to a similar extent in the allogenic response (data not shown). On average, antigenreactive bT cells divide 2.4 times and abT cells 3.6 times within 4 days (burst sizes). The proliferative capacity of abT cells compared with bT cells was three times higher (31 versus 9, respectively).
To examine whether bT cells are capable of effector function, the production of GrB was analysed by flow cytometry following 10 days in vitro re-stimulation of bT and abT cells with allogenic P815 and syngenic EL4 cells, respectively (Fig. 5C) . Interestingly, 61% of CD8 + bT cells produce GrB, compared with 48% of CD8 ÿ bT cells. 
Discussion
Prior to the acquisition of the second receptor chain, lymphoid precursors express surrogate IgL and pTa chains that allow IgH and TCRb chains to assemble into pre-BCR and pre-TCR complexes, respectively. In terms of structure, composition and signalling function, these precursor forms of AgRs are very similar to AgRs on mature lymphocytes and are critical checkpoints in controlling the development of precursor lymphocytes. Once, expression of the surrogate AgR is achieved, V to J rearrangement at Ig light and TCRa chain gene loci commences, which eventually leads to the replacement of the surrogate chain by Igj or k light chains or the TCRa chain. Thus, the assembly of AgRs is a prerequisite for and parallels lymphocyte development. The final differentiation of bone marrow-derived IgM-expressing B cells and thymus-derived abT cells is associated with a transcriptional termination of VpreB/k5 and pTa chain expression, respectively. While pTa ÿ/ÿ mice clearly identified a critical function of the pTa chain in early T cell development (23), constitutive surface expression of the pre-TCR is required to address the developmental potential beyond b-selection. Transgenic mice were derived that express pTa under transcriptional control elements of the TCRb locus, in the absence of TCRa chains. In this setup, three possibilities can be envisaged. (i) Maturation of thymocytes does not take place in the absence of the TCRa chain. (ii) Due to constitutive expression and autonomous signalling by the pre-TCR in the absence of ligand binding (17, 33) , most thymocytes mature. (iii) Selective pre-TCRs are capable of interaction with MHC molecules, driving maturation of some but not all thymocytes. In the latter case, only a subset of thymocytes is expected to mature and might even be capable of responding to allogenic MHC molecules. Here, we clearly demonstrate that constitutive expression of pTa indeed allows a small fraction of b-selected DP thymocytes to mature into post-thymic, peripheral T cells. The pTa/TCRb-expressing thymocytes develop into CD8 + and some into CD4 + co-receptor-positive cells indicating that lineage commitment does not necessitate expression of TCRa chains. That only 1-3% of bT cells express the CD4 co-receptor suggests that pre-TCR signals do not deliver the sustained signalling thought to be required for CD4 SP differentiation (for review see 16) . The Vb usage of bT cells is comparable to abT cells, suggesting that all segments can promote the development of bT cells (data not shown). No reaction was observed for bT cells in a mixed primary lymphocyte reaction of bT cells with allogenic irradiated Balb/c splenocytes. Yet, MHC recognition by bT cells is suggested by the ability of bT cells to respond to allogenic MHC in a recall response, although we cannot exclude that allorecognition is due to another receptor than the pre-TCR at present. Subsequent experiments are required to address whether the pre-TCR is the relevant antigen recognition unit. These observations contrast a similar study in which CD8 + / CD3 low cells developed when a pTa transgene was placed under the proximal lck promotor (34) . Based on northern blotting from total non-sorted LN tissue, these CD8 + cells were interpreted to be pTa negative and capable of developing normally in an MHC-deficient environment, suggesting that recognition of MHC antigens by the pre-TCR is not required for thymic selection. Either our bT cells (Fig. 2C) differ from the lckdriven pTa tg T cells with regard to pre-TCR expression (34), or alternatively, the pre-TCR is expressed and non-classical MHC molecules or leaky MHC class I heavy chains support the development of CD8 + cells. Therefore, constitutive ligandindependent tickling by the pre-TCR is quite unlikely to explain the inefficient intra-thymic maturation of bT cells, as has been previously suggested (34) . Our observations that bT cells do express the pre-TCR (Fig. 2C) , resemble small resting T cells lacking expression of activation markers and seem to be capable of alloresponse (Fig. 5 ) are in line with the maturation of a very small subset of b-selected thymocytes into mature small resting bT cells.
Two opposing evolutionary scenarios could explain the existence of pTa: (i) the pTa chain evolved after TCRab to fulfil its function in b-selection (35) and (ii) prior to the evolution of TCRa, the pTa/TCRb heterodimer resembled an immunocompetent AgR. Two predictions can be derived from the latter scenario. First, the pre-TCR should be able to mediate cognate antigen recognition of self-MHC molecules. Here, the pre-TCR antigen recognition would largely be determined by the TCRb chain. Second, precursor T lymphocytes expressing the pre-TCR constitutively throughout development would undergo intra-thymic selection and maturation. Our data are in favour of the second scenario.
In addition, since AgRs are generated by somatic recombination of two complex gene loci, it is very unlikely that they have evolved simultaneously. Based on these considerations, we would like to propose an alternative model, in which the sequential rearrangement of AgR chains during lymphocyte development resembles a time lapse of lymphocyte and AgR evolution. In this scenario, the development of lymphocytes from lymphoid progenitors might recapitulate the stepwise acquisition of complex AgR gene loci during evolution. Accordingly, the maintenance of the non-rearranging surrogate receptor chain genes throughout evolution reflects the necessity of lymphocytes to receive AgR signals that warrant survival at each stage of their development (2, 4, 5, 36, 37) .
Crystallographic analysis of TCRab-pMHC complexes have revealed that specific recognition of the pMHC complex by the TCRab can be largely determined by the Va domain, the Vb domain or both (13, 14, 38, 39) . These data indicate that a single Vb domain is principally capable of pMHC recognition. We show here that indeed the Vb domain can be sufficient to allow T cell development in the absence of the TCRa chain generating immunocompetent bT cells. We speculate that with the evolution of the TCRa locus, the pTa locus got modified such that it fulfils a function in b-selection only. During this process, it might have been important to delay thymic selection and delete TCR Va-like domains within the pre-TCR. This will prevent that abT cell precursors are selected twice, first on the basis of the pre-TCR specificity (which is not relevant) and second on the basis of the specificity of the clonotypic TCRab (which is relevant).
